Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure.
about
Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor.The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors.New insights into the stereochemical requirements of the bradykinin B2 receptor antagonists binding.Pharmacological characterization of ligand-receptor interactions at the zebrafish bradykinin receptor.Effect of a toggle switch mutation in TM6 of the human adenosine A₃ receptor on Gi protein-dependent signalling and Gi-independent receptor internalization.A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revertant mutations.Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B₂ receptor.A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.Preliminary mutational analysis of the human kinin B2 receptor for nonpeptide antagonist ligands recognition.Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.Comparative analysis of putative agonist-binding modes in the human A1 adenosine receptor.Optical biosensor provides insights for bradykinin B(2) receptor signaling in A431 cells.Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
P2860
Q34118123-C6E6313C-E1F9-4520-94F8-AF62FF768355Q34313795-E7FDB9B0-4DC4-46E6-8C47-3006981DDFB1Q40177843-A584E264-4532-4178-8FB9-369CA7F12783Q40472792-666FFEA7-77FD-4847-A712-FC00A62B14EDQ42176971-E7F10539-AD87-4120-941F-556D9D22CAAFQ42241635-9AB67015-A254-426C-BDFC-D3DA5D59D7A3Q42524236-787A7707-8914-48F7-957C-B03D21EBE54BQ42663640-5D458419-2162-4C58-BCE4-DAC7555133EFQ43263223-234F78DF-A5BA-43A9-BD57-A634E5027B20Q44003391-3114CDA6-1910-47A4-B35C-89B502043099Q44582560-977BAA9B-521F-4935-8974-91D0D796ADF4Q44918711-260C74B9-6536-4C3C-961D-C1AEC8CF7DC4Q46785891-070D4429-1B53-472F-B0D9-55091199102FQ46959714-19E53AEF-A53D-4452-BDFB-246E48C7DA51
P2860
Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Control of conformational equi ...... on to the rhodopsin structure.
@en
Control of conformational equi ...... on to the rhodopsin structure.
@nl
type
label
Control of conformational equi ...... on to the rhodopsin structure.
@en
Control of conformational equi ...... on to the rhodopsin structure.
@nl
prefLabel
Control of conformational equi ...... on to the rhodopsin structure.
@en
Control of conformational equi ...... on to the rhodopsin structure.
@nl
P2093
P2860
P356
P1476
Control of conformational equi ...... son to the rhodopsin structure
@en
P2093
Bonnafous JC
Groblewski T
Larguier R
Vassault P
P2860
P304
41100-41111
P356
10.1074/JBC.M104875200
P407
P50
P577
2001-08-08T00:00:00Z